Literature DB >> 33401522

MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment.

Federico Virga1,2,3, Lorena Quirico1,2, Stefania Cucinelli1,2, Massimiliano Mazzone1,2,3, Daniela Taverna1,2, Francesca Orso1,2.   

Abstract

The metabolism of cancer cells is generally very different from what is found in normal counterparts. However, in a tumor mass, the continuous crosstalk and competition for nutrients and oxygen among different cells lead to metabolic alterations, not only in cancer cells, but also in the different stromal and immune cells of the tumor microenvironment (TME), which are highly relevant for tumor progression. MicroRNAs (miRs) are small non-coding RNAs that silence their mRNA targets post-transcriptionally and are involved in numerous physiological cell functions as well as in the adaptation to stress situations. Importantly, miRs can also be released via extracellular vesicles (EVs) and, consequently, take part in the bidirectional communication between tumor and surrounding cells under stress conditions. Certain miRs are abundantly expressed in stromal and immune cells where they can regulate various metabolic pathways by directly suppressing enzymes or transporters as well as by controlling important regulators (such as transcription factors) of metabolic processes. In this review, we discuss how miRs can induce metabolic reprogramming in stromal (fibroblasts and adipocytes) and immune (macrophages and T cells) cells and, in turn, how the biology of the different cells present in the TME is able to change. Finally, we debate the rebound of miR-dependent metabolic alterations on tumor progression and their implications for cancer management.

Entities:  

Keywords:  metabolism; miR; tumor microenvironment

Year:  2021        PMID: 33401522      PMCID: PMC7795884          DOI: 10.3390/cancers13010127

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  112 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

2.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

3.  MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.

Authors:  Xiang Fei; Manlong Qi; Bin Wu; Yongsheng Song; Yueping Wang; Tingting Li
Journal:  FEBS Lett       Date:  2012-01-16       Impact factor: 4.124

4.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 5.  IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2016-01-31       Impact factor: 16.687

6.  miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism.

Authors:  Tengfei Zhang; Zhen Zhang; Feng Li; Yu Ping; Guohui Qin; Chaoqi Zhang; Yi Zhang
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

7.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 8.  Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.

Authors:  Xixi Zhao; Jingkun Qu; Yuchen Sun; Jizhao Wang; Xu Liu; Feidi Wang; Hong Zhang; Wen Wang; Xingcong Ma; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-05-02

Review 9.  Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis.

Authors:  Akiko Kogure; Nobuyoshi Kosaka; Takahiro Ochiya
Journal:  J Biomed Sci       Date:  2019-01-12       Impact factor: 8.410

10.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.

Authors:  Cristovão M Sousa; Douglas E Biancur; Xiaoxu Wang; Christopher J Halbrook; Mara H Sherman; Li Zhang; Daniel Kremer; Rosa F Hwang; Agnes K Witkiewicz; Haoqiang Ying; John M Asara; Ronald M Evans; Lewis C Cantley; Costas A Lyssiotis; Alec C Kimmelman
Journal:  Nature       Date:  2016-08-10       Impact factor: 49.962

View more
  3 in total

1.  SMOX expression predicts the prognosis of non-small cell lung cancer.

Authors:  Zhanghao Huang; Shuo Wang; Hai-Jian Zhang; You Lang Zhou; Jia-Hai Shi
Journal:  Ann Transl Med       Date:  2021-07

2.  Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma.

Authors:  Shoubin Sun; Runze Wang; Sisi Yi; Sijia Li; Lei Wang; Jianwen Wang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

3.  Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells.

Authors:  Jing Zhang; Jingjing Zhu; Genhui Zheng; Qianyu Wang; Xiaorui Li; Yaru Feng; Fengqin Shang; Siqi He; Qiyao Jiang; Bingjie Shi; Dong Wang; Zhiwei Cao; Jianxun Wang
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.